Redcare Pharmacy stock: Q3 profit turns positive as Rx drives growth

Published on 10/29/2026 at 17:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Redcare Pharmacy (Shop Apoth) stock follows a quarter of stronger profitability and continued German prescription growth. Management kept its upgraded 2026 outlook.

Q3 growth meets stronger profitability

Prescription revenue in Germany continued to expand strongly, while non-prescription growth was softer in October.
Management confirmed the upgraded full-year 2026 revenue and adjusted EBITDA margin outlook.
The company is targeting positive free cash flow in 2027 as it balances customer investment with profitability.

Redcare Pharmacy, NL0012044747, Illustration mit AI erstellt.

Redcare Pharmacy reported a stronger third quarter on October 29, 2026, with prescription medicines again driving growth and profitability improving. The figures come from the company's EQS release published by Deutsche Boerse.

Rx momentum supports the quarter

Group revenue rose 18% year over year to EUR 847 million in Q3 2026. Rx revenue increased 31% to EUR 358 million, including 56% growth in Germany to EUR 197 million. Non-Rx revenue rose 9% to EUR 489 million, while the active customer base reached 15.2 million at the end of September.

Adjusted EBITDA increased 68% year over year to EUR 28.7 million, lifting the margin to 3.4% from 2.4%. Net income was positive at EUR 1 million for the second consecutive quarter, and free cash flow reached EUR 15 million in the quarter. The company said gross-margin pressure eased, with the group margin down 0.3 percentage points year over year.

Guidance remains unchanged

Redcare confirmed its upgraded 2026 targets: total revenue growth of 16% to 18%, non-Rx growth of 10% to 12%, German Rx revenue of EUR 730 million to EUR 760 million and an adjusted EBITDA margin of 2.5% to 3.0%. Management also said October non-Rx growth was running below 10% because cough-and-cold sales started slowly. It is targeting positive free cash flow in 2027.

Share price and investor context

At Lang & Schwarz, the stock stood at EUR 75.15 at 17:06:57 Berlin time on October 29. The Xetra close was EUR 75.05, down 5.30% from the EUR 79.25 close on October 28. This market move is shown separately from the operating update. Since the previous own report's EUR 78.28 pre-market indication on October 28, the Lang & Schwarz quote is down 4.00%. Investors can follow the real-time quote of Redcare Pharmacy (Shop Apoth) stock.